XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation and Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
The Company recorded stock-based compensation expense in the following expense categories of its accompanying unaudited interim condensed statements of operations and comprehensive loss (in thousands):

Three Months Ended March 31,
20242023
Research and development$1,255 $814 
General and administrative1,221 869 
Total stock-based compensation$2,476 $1,683 
Schedule of option activity
The following table summarizes option activity under the 2020 Plan:
Options
Weighted
Average
Exercise Price
Weighted
Average
Remaining Life
(Years)
Balance at December 31, 20234,942,164 $7.21 7.62
Granted1,784,068 9.94 
Exercised(138,555)4.30 
Forfeited(118,818)10.48 
Balance at March 31, 20246,468,859 $7.96 7.86
Vested and expected to vest6,134,411 $7.93 7.78
Exercisable at the end of the period3,043,909 $7.89 6.47
Schedule of RSU activity
The following table summarizes employee RSU activity for the three months ended March 31, 2024:
Awards
Weighted
Average
Grant Date Fair Value
Unvested RSUs as of December 31, 2023
590,403 $4.80 
Granted638,476 10.09 
Released(156,803)5.16 
Forfeited(31,455)4.97 
Unvested RSUs as of March 31, 2024
1,040,621 $7.99 
Schedule of valuation assumptions
The grant-date fair value of options calculated using the Black-Scholes option pricing model granted under the Company’s 2020 Plan were estimated using the following weighted-average assumptions:
Three Months Ended March 31,
20242023
2020 Plan:
Expected term - years6.086.08
Expected volatility95.8%84.8%
Risk-free interest rate4.0%3.5%
Expected dividends
The grant-date fair value of options calculated using the Monte Carlo option pricing model granted under the Company’s 2020 Plan were estimated using the following assumptions:
Three Months Ended March 31,
20242023
2020 Plan:
Expected term - years0.004.00
Expected volatility— %80.0 %
Risk-free interest rate— %3.6 %
Expected dividends— — 
The grant-date fair value of shares issued calculated using the Black-Scholes option pricing model under the Company’s 2020 ESPP were estimated using the following weighted-average assumptions:
Three Months Ended March 31,
20242023
2020 ESPP:
Expected term - years0.500.49
Expected volatility158.6 %84.8 %
Risk-free interest rate5.1 %3.5 %
Expected dividends— —